Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats (original) (raw)

Basic Study

Copyright ©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.

World J Gastroenterol. Jul 7, 2015; 21(25): 7777-7785
Published online Jul 7, 2015. doi: 10.3748/wjg.v21.i25.7777

Figure 2 Effects of berberine on fasting plasma insulin level and homeostasis model assessment of insulin resistance in diabetic rats. Each bar represents the mean ± SD (n = 8). b_P_ < 0.01 vs the normal control group; d_P_ < 0.01 vs the model group (by ANOVA). HOMA-IR: Homeostasis model assessment of insulin resistance.

• Citation: Jiang SJ, Dong H, Li JB, Xu LJ, Zou X, Wang KF, Lu FE, Yi P. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats. World J Gastroenterol 2015; 21(25): 7777-7785
• URL: https://www.wjgnet.com/1007-9327/full/v21/i25/7777.htm
• DOI: https://dx.doi.org/10.3748/wjg.v21.i25.7777